Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial
Published: 13 February 2023| Version 1 | DOI: 10.17632/2648w95g9x.1
Contributor:
Xin Liu
Description
This data is for "Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial".
Files
Categories
Surgery, Chemotherapy